Dr. Loven is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 Bluebird Dr
Goodlettsville, TN 37072Phone+1 615-859-7546Fax+1 615-851-7760
Education & Training
Virginia Commonwealth University Health SystemResidency, Dermatology, 1984 - 1987
Indiana University School of MedicineInternship, Internal Medicine, 1983 - 1984
Vanderbilt University School of MedicineClass of 1983
Certifications & Licensure
TN State Medical License 1987 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Top MD Consumers Checkbook
- Fellow (FAAD) American Academy of Dermatology
- Join now to see all
Clinical Trials
- Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2014 Apr 01
- Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
- Study of Glycopyrronium in Axillary Hyperhydrosis Start of enrollment: 2015 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 98 citationsEvaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosisKeith Loven, Linda Stein, Katharine Furst, Sharon F. Levy
Clinical Therapeutics. 2002-06-01 - 248 citationsA randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasisGerald G. Krueger, Kim A. Papp, Dow Stough, Keith H. Loven, Wayne Gulliver
Journal of the American Academy of Dermatology. 2002-12-01 - 36 citationsA multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of...Guy F. Webster, Lyn Guenther, Yves Poulin, Barry A Solomon, Keith Loven
Cutis. 2002-02-01
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
